These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Cells producing recombinant retrovirus with thymidine kinase gene from Herpes simplex virus suitable for human cancer gene therapy. Hlavatý J; Hlubinová K; Bies J; Altaner C Neoplasma; 1999; 46(6):329-34. PubMed ID: 10732860 [TBL] [Abstract][Full Text] [Related]
44. The anti-glioma effect of suicide gene therapy using BMSC expressing HSV/TK combined with overexpression of Cx43 in glioma cells. Huang Q; Liu XZ; Kang CS; Wang GX; Zhong Y; Pu PY Cancer Gene Ther; 2010 Mar; 17(3):192-202. PubMed ID: 19851353 [TBL] [Abstract][Full Text] [Related]
45. [Gene therapy for malignant glioma]. Mizuno M; Yoshida J Nihon Rinsho; 2005 Mar; 63(3):469-75. PubMed ID: 15773347 [TBL] [Abstract][Full Text] [Related]
46. [Controlled multimodality treatment of brain stem gliomas]. Kito A; Yoshida J; Kageyama N No Shinkei Geka; 1987 Jul; 15(7):797-803. PubMed ID: 2823158 [TBL] [Abstract][Full Text] [Related]
47. Paediatric high and low grade glioma: the impact of tumour biology on current and future therapy. Hargrave D Br J Neurosurg; 2009 Aug; 23(4):351-63. PubMed ID: 19637006 [TBL] [Abstract][Full Text] [Related]
48. Long-term rat survival after malignant brain tumor regression by retroviral gene therapy. Izquierdo M; Cortés M; de Felipe P; Martín V; Díez-Guerra J; Talavera A; Perez-Higueras A Gene Ther; 1995 Jan; 2(1):66-9. PubMed ID: 7712334 [TBL] [Abstract][Full Text] [Related]
49. Defective herpes simplex virus vectors expressing thymidine kinase for the treatment of malignant glioma. Miyatake S; Martuza RL; Rabkin SD Cancer Gene Ther; 1997; 4(4):222-8. PubMed ID: 9253507 [TBL] [Abstract][Full Text] [Related]
50. [The effectiveness of interferon-beta against glioma cells and its augmentation of growth inhibitory effect by transfection of its gene]. Wakabayashi T; Mizuno M; Yoshida J Hum Cell; 1995 Sep; 8(3):95-8. PubMed ID: 8652452 [TBL] [Abstract][Full Text] [Related]
51. Gene therapy of central nervous system tumors. Wakabayashi T; Mizuno M; Yoshida J Neurol Med Chir (Tokyo); 1998 Nov; 38(11):763-71. PubMed ID: 9919911 [TBL] [Abstract][Full Text] [Related]
52. Understanding high grade glioma: molecular mechanism, therapy and comprehensive management. Wang Y; Jiang T Cancer Lett; 2013 May; 331(2):139-46. PubMed ID: 23340179 [TBL] [Abstract][Full Text] [Related]
53. [Current theories on the treatment of glial (malignant) brain tumors]. Koziak M; Kuran W Neurol Neurochir Pol; 1983; 17(4):495-502. PubMed ID: 6316186 [No Abstract] [Full Text] [Related]
55. Delivery of local therapeutics to the brain: working toward advancing treatment for malignant gliomas. Chaichana KL; Pinheiro L; Brem H Ther Deliv; 2015 Mar; 6(3):353-69. PubMed ID: 25853310 [TBL] [Abstract][Full Text] [Related]
56. [Repetitive resection and intrasurgery radiation therapy of brain malignant gliomas: history of question and modern state of problem]. Abdullayev OA; Gaitan AS; Salim N; Sergeyev GS; Marmazeyev IV; Chesnulis E; Goryainov SA; Krivoshapkin AL Zh Vopr Neirokhir Im N N Burdenko; 2019; 83(5):101-108. PubMed ID: 31825381 [TBL] [Abstract][Full Text] [Related]
57. Management of malignant brain tumors. Hildebrand J; Dewitte O; Dietrich PY; de Tribolet N Eur Neurol; 1997; 38(3):238-53. PubMed ID: 9363837 [TBL] [Abstract][Full Text] [Related]